Highlights
NYSE: RCUS       Arcus Biosciences Inc
Last Price Today's Change   Day's Range   Trading Volume
24.05   +0.67 (2.87%)  22.515 - 24.90  775,100

Overview

 
Avg Volume (4 weeks):880,178
4 Weeks Range:22.155 - 30.704
4 Weeks Price Volatility (%):
22.17%
52 Weeks Range:6.30 - 37.41
52 Weeks Price Volatility (%):
57.06%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company which focuses on creating innovative cancer immunotherapies by leveraging underexploited biological opportunities. The company focuses on an ATP-adenosine pathway which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. The pipeline products of the company include dual and selective A2R antagonists, small-molecule and antibody programs which target solid tumors. The company operates through the single segment being the business of developing and commercializing immunotherapies.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2452  5804  513  138 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 ZOM 0.168-0.057 
 GNUS 3.55+1.24 
 NIO 9.38+1.47 
 LK 1.38-1.62 
 SOLO 3.13+0.80 
 WKHS 20.91+1.73 
 AAL 12.50-0.31 
 JOB 1.50+0.986 
 SQQQ 7.14-0.15 
 GE 6.82+0.08 
Partners & Brokers